GlassScriptPhysician profile
Vincent C Narciso
NPI 1871685685
$10,100.55
in general payments reported to CMS, 2019-2025
32 companies · $2,195 in 2025
The $2,195 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,003 · 2020: $191 · 2021: $332 · 2022: $1,228 · 2023: $1,554 · 2024: $3,599 · 2025: $2,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,999 · Travel and Lodging: $1,849 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,998.71 |
| Travel and Lodging | $1,848.76 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,915.80 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Intuitive Surgical, INC. | $2,839.70 | 2019-2025 | |
| Sanara Medtech INC. | $725.87 | 2023 | Celleraterx |
| Acera Surgical, INC. | $548.54 | 2019-2025 | Restrata Wound Matrix |
| Baxter Healthcare | $453.30 | 2019-2025 | Perclot |
| Kerecis Limited | $395.87 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Stryker Corporation | $389.08 | 2022-2025 | Artix Mt |
| Covidien LP | $243.84 | 2019 | |
| Ethicon US, LLC | $206.72 | 2019-2020 | |
| Tela Bio, INC. | $176.64 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $151.45 | 2021-2025 | Maxtack, Transorb |
| Becton, Dickinson and Company | $111.91 | 2024 | Phasix Mesh |
| Endogastric Solutions, INC | $100.12 | 2023 | Esophyx |
| Conmed Corporation | $100.00 | 2021 | |
| Innovation Technologies INC | $80.55 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $78.22 | 2019-2022 | |
| Abbvie INC. | $70.40 | 2023 | |
| Innocoll Pharmaceuticals Limited | $70.09 | 2021-2022 | |
| Teleflex LLC | $62.57 | 2022-2025 | Quikclot |
| Ambu INC. | $55.05 | 2022 | |
| Aroa Biosurgery Incorporated | $53.89 | 2025 | |
| W. L. Gore & Associates, INC. | $44.94 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Merck Sharp & Dohme LLC | $43.71 | 2019 | |
| Phathom Pharmaceuticals, INC. | $39.44 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $27.20 | 2022 | |
| Daiichi Sankyo INC. | $22.66 | 2022 | |
| Olympus America INC. | $16.48 | 2019 | |
| Shire North American Group INC | $16.09 | 2019 | |
| Kci USA, INC. | $16.04 | 2019 | |
| Baudax Bio INC. | $15.71 | 2022 | |
| Boston Scientific Corporation | $15.59 | 2021 | |
| Endo Pharmaceuticals INC. | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Narciso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.